State Street’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
Other funds holding HOWL
RCM
VCM
MB
LCM
SFM
DF
SCM
State Street's HOWL Position: Q1 2026 in Review
State Street held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 119,168 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4027.
State Street first reported a position in HOWL in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.09M in Q4 2021. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.
- State Street held 119,168 shares of Werewolf Therapeutics worth $99.2K as of Q1 2026.
- State Street left its Werewolf Therapeutics share count unchanged in Q1 2026.
- Werewolf Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4027 holding.
- State Street first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 20 quarters since.
- State Street's Werewolf Therapeutics position peaked at $3.09M in Q4 2021.
- 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.